DNA Methylation Markers in Health and Disease
A special issue of Epigenomes (ISSN 2075-4655).
Deadline for manuscript submissions: 31 December 2025 | Viewed by 34
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, “DNA Methylation Markers in Health and Disease”, aims to explore the critical role of DNA methylation as a biomarker in physiological and pathological processes. DNA methylation, a key epigenetic mechanism, regulates gene expression and genomic stability, influencing development, aging, and disease progression. This issue will highlight advances in identifying methylation-based biomarkers for early diagnosis, prognosis, and therapeutic monitoring in cancer, neurological disorders, cardiovascular diseases, and other conditions. We invite original research, reviews, and methodological studies that investigate novel methylation signatures, their functional implications, and clinical applications. Contributions may also address technological innovations in methylation profiling, bioinformatics tools, and the integration of epigenomic data with other omics layers. By compiling cutting-edge research, this Special Issue seeks to enhance the understanding of DNA methylation's role in health and disease, fostering translational breakthroughs for precision medicine.
Dr. Osman El‐Maarri
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Epigenomes is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- DNA methylation
- epigenetic biomarkers
- disease diagnostics
- precision medicine
- methylation profiling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
